Drug intelligence / Profile preview

Adrenaline, Noradrenaline, Dopamine, and Dobutamine Combination

Development stage
Unknown
Administration
Intravenous, Intraosseous
01

Overview

The combination "adrenaline + noradrenaline + dopamine + dobutamine" refers to four distinct sympathomimetic medications that are commonly used in critical care settings for cardiovascular support. These drugs are not typically administered as a single formulation but are used individually or in specific combinations based on clinical needs. ## Individual Components **Adrenaline (Epinephrine)** Adrenaline is a potent nonselective adrenergic agonist that stimulates both α and β receptors. It increases heart rate, contractility, and causes vasoconstriction, leading to increased blood pressure[1][3]. It's commonly used in cardiac arrest, anaphylaxis, and shock states. **Noradrenaline (Norepinephrine)** Norepinephrine primarily stimulates α-receptors causing vasoconstriction, with some β1 activity that increases cardiac contractility[2][6]. It's considered a first-line vasopressor in septic shock and other hypotensive states[6][8]. **Dopamine** Dopamine has dose-dependent effects: at low doses (1-4 μg/kg/min) it primarily affects dopaminergic receptors increasing renal and mesenteric blood flow; at intermediate doses (4-10 μg/kg/min) it has significant β1 effects increasing cardiac output; at higher doses (>10 μg/kg/min) it has α-adrenergic effects causing vasoconstriction[5][6]. **Dobutamine** Dobutamine is predominantly a β1-agonist that increases cardiac contractility with minimal effect on heart rate[2][6]. It's the first-line inotropic agent for cardiogenic shock and heart failure with low cardiac output[6]. ## Clinical Applications of Combinations These medications are sometimes used in combination for specific clinical scenarios: 1. **Norepinephrine + Dobutamine**: This is a common combination in septic shock when patients need both vasopressor support (norepinephrine) and inotropic support (dobutamine)[4][6]. Dobutamine helps improve cardiac output while norepinephrine maintains blood pressure. 2. **Norepinephrine + Epinephrine**: This combination has been studied in septic shock, showing positive effects on cardiovascular parameters but potentially negative effects on serum lactate and pH compared to norepinephrine plus dobutamine[4]. 3. **Multiple Agent Combinations**: In complex shock states, particularly post-cardiac surgery, combinations of three or more agents may be used (e.g., epinephrine + norepinephrine + dobutamine)[8]. Each drug has distinct receptor affinities and hemodynamic effects, allowing clinicians to tailor therapy to specific patient needs. The choice of agent(s) depends on the underlying pathophysiology, hemodynamic goals, and patient response.

Other names
Epinephrine, Norepinephrine, Dopamine, and Dobutamine CombinationQuadruple Vasoactive Agent Therapy
02

Targets

ADRA2 (Adrenergic alpha-2 receptor family)ADRA1 (Alpha-1 adrenergic receptor family)D1-like (D1-like dopamine receptor)ADRB1 (β1)DRD4 (Dopamine D4 Receptor)

Beyond the preview

Go deeper on Adrenaline, Noradrenaline, Dopamine, and Dobutamine Combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adrenaline, Noradrenaline, Dopamine, and Dobutamine Combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call